Osteoporosis medication adherence is poor

Share this article:
Adherence to osteoporosis medications is relatively poor, according to recent article in the journal Drugs & Aging. About 20% to 30% of patients taking daily or weekly treatments may suspend use within six to 12 months of initiating therapy, a study appearing in the January issue said.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.